TCL Archive House panel gives NIH 0.5 percent increase, matching the President’s budget request. June 17, 2005
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006